December 18, 2024
TOPLINE: Higher doses and a longer duration of buprenorphine use throughout pregnancy for opioid use disorder (OUD) are associated with improved postpartum treatment retention and fewer […]
December 18, 2024
TOPLINE: The presence of cardiovascular comorbidities has minimal effect on the efficacy of inhaled or oral treprostinil when used alongside oral monotherapy in patients with pulmonary […]
December 18, 2024
TOPLINE: Mannkind Corporation expects to submit a request for a supplemental new drug application meeting to the US Food and Drug Administration for its inhaled human […]
December 18, 2024
TOPLINE: Corticosteroids neither reduce all-cause mortality nor increase serious adverse events in patients with HIV and tuberculosis coinfection. METHODOLOGY: Researchers evaluated the efficacy and safety of […]
December 18, 2024
TOPLINE: First-degree family history of mental illness is significantly associated with increased aggression in individuals exposed to repetitive head impact and with chronic traumatic encephalopathy (CTE), […]
December 17, 2024
TOPLINE: Among 504 pregnant individuals, 46.8% reported using cannabis during pregnancy, with 58.1% citing mental health reasons. Cannabis use did not accelerate improvement in depression or […]
December 17, 2024
TOPLINE: In the largest study of its kind to date covering around 3.2 million children, Scandinavian investigators have found that recent use (≤ 3 months before […]
December 17, 2024
TOPLINE: Pregnancies in women with pre-existing type 2 diabetes (T2D) are associated with greater perinatal mortality than other forms of diabetes in pregnancy. Congenital malformations and […]
December 17, 2024
TOPLINE: Patients with painful chronic pancreatitis and a dilated pancreatic duct benefit more from early surgical intervention than an endoscopy-first approach in the long term. METHODOLOGY: […]